Skip to main content
Top
Published in: BMC Public Health 1/2017

Open Access 01-12-2017 | Research article

Prices of over-the-counter drugs used by 15-year-old adolescents in Germany and their association with socioeconomic background

Authors: Salvatore Italia, Silke B. Wolfenstetter, Irene Brüske, Joachim Heinrich, Dietrich Berdel, Andrea von Berg, Irina Lehmann, Marie Standl, Christina M. Teuner

Published in: BMC Public Health | Issue 1/2017

Login to get access

Abstract

Background

In Germany, over-the-counter (OTC) drugs are normally reimbursed up to the age of 12 years only. The aim of this study was to analyse prices of over-the-counter drugs used by adolescents in Germany and their association with socioeconomic factors.

Methods

Based on the German GINIplus and LISAplus birth cohorts, data on drug utilization among 15-year-old adolescents (n = 4677) were collected using a self-administered questionnaire. The reported drugs were subdivided into prescription drugs and OTC drugs. The drugs’ prices were tracked by the pharmaceutical identification numbers.

Results

Overall, 1499 OTC drugs with clearly identifiable prices were eligible for analysis. Their mean price was €9.75 (95% confidence interval: €9.27–10.22). About 75% of the OTC drugs cost less than €10. Higher mean prices were associated with residing in Munich (€10.74; 95% confidence interval: €9.97–11.52) and with higher paternal education (e.g. highest education level: €10.17; 95% confidence interval: €9.47–10.86). Adolescents residing in Munich (in comparison with the less wealthy region of Wesel) and adolescents with higher educated fathers were also significantly more likely to use OTC drugs costing ≥ €10 or ≥ €25, respectively.

Conclusions

The price of €10 for non-reimbursable OTC drugs may represent a (psychological) threshold. Higher prices could discourage especially adolescents from a lower socioeconomic background from taking medically advisable but non-reimbursable OTC drugs.
Literature
1.
go back to reference Martikainen J, Rajaniemi S. Drug reimbursement systems in EU member states, Iceland and Norway. Helsinki: The Social Insurance Institution, Finland, Social security and health reports 54; 2002. Martikainen J, Rajaniemi S. Drug reimbursement systems in EU member states, Iceland and Norway. Helsinki: The Social Insurance Institution, Finland, Social security and health reports 54; 2002.
5.
go back to reference Italia S, Brand H, Heinrich J, Berdel D, von Berg A, Wolfenstetter SB. Utilization of self-medication and prescription drugs among 15-year-old children from the German GINIplus birth cohort. Pharmacoepidemiol Drug Saf. 2015;24:1133–44. 10.1002/pds.3829.CrossRefPubMed Italia S, Brand H, Heinrich J, Berdel D, von Berg A, Wolfenstetter SB. Utilization of self-medication and prescription drugs among 15-year-old children from the German GINIplus birth cohort. Pharmacoepidemiol Drug Saf. 2015;24:1133–44. 10.​1002/​pds.​3829.CrossRefPubMed
7.
go back to reference Heinrich J, Brüske I, Schnappinger M, Standl M, Flexeder C, Thiering E, et al. Die zwei deutschen Geburtskohorten GINIplus und LISAplus [Two German Birth Cohorts: GINIplus and LISAplus]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55:864–74. 10.1007/s00103-012-1485-4.CrossRefPubMed Heinrich J, Brüske I, Schnappinger M, Standl M, Flexeder C, Thiering E, et al. Die zwei deutschen Geburtskohorten GINIplus und LISAplus [Two German Birth Cohorts: GINIplus and LISAplus]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55:864–74. 10.​1007/​s00103-012-1485-4.CrossRefPubMed
14.
go back to reference Italia S, Batscheider A, Heinrich J, Wenig C, Bauer CP, Koletzko S, Lehmann I, Herbarth O, von Berg A, Berdel D, Hoffmann B, Schaaf B, Wolfenstetter SB. Utilization and costs of conventional and alternative pharmaceuticals in children: results from the German GINIplus and LISAplus birth cohort studies. Pharmacoepidemiol Drug Saf. 2012;21:1102–11. 10.1002/pds.3323.CrossRefPubMed Italia S, Batscheider A, Heinrich J, Wenig C, Bauer CP, Koletzko S, Lehmann I, Herbarth O, von Berg A, Berdel D, Hoffmann B, Schaaf B, Wolfenstetter SB. Utilization and costs of conventional and alternative pharmaceuticals in children: results from the German GINIplus and LISAplus birth cohort studies. Pharmacoepidemiol Drug Saf. 2012;21:1102–11. 10.​1002/​pds.​3323.CrossRefPubMed
15.
go back to reference Italia S, Brüske I, Heinrich J, Berdel D, von Berg A, Lehmann I, Standl M, Wolfenstetter SB. A longitudinal comparison of drug use among 10-year-old children and 15-year-old adolescents from the German GINIplus and LISAplus birth cohorts. Eur J Clin Pharmacol. 2015;72:301–10. 10.1007/s00228-015-1977-x.CrossRefPubMedPubMedCentral Italia S, Brüske I, Heinrich J, Berdel D, von Berg A, Lehmann I, Standl M, Wolfenstetter SB. A longitudinal comparison of drug use among 10-year-old children and 15-year-old adolescents from the German GINIplus and LISAplus birth cohorts. Eur J Clin Pharmacol. 2015;72:301–10. 10.​1007/​s00228-015-1977-x.CrossRefPubMedPubMedCentral
17.
go back to reference Grossman D, Fuentes L. Over-the-counter access to oral contraceptives as a reproductive healthcare strategy. Curr Opin Obstet Gynecol. 2013;25:500–5.CrossRefPubMed Grossman D, Fuentes L. Over-the-counter access to oral contraceptives as a reproductive healthcare strategy. Curr Opin Obstet Gynecol. 2013;25:500–5.CrossRefPubMed
20.
go back to reference Sundmacher L, Ozegowski S. Ziehen Privatpatienten Ärzte an. Gesundheit und Gesellschaft. 2013;12/13:31–5. Sundmacher L, Ozegowski S. Ziehen Privatpatienten Ärzte an. Gesundheit und Gesellschaft. 2013;12/13:31–5.
Metadata
Title
Prices of over-the-counter drugs used by 15-year-old adolescents in Germany and their association with socioeconomic background
Authors
Salvatore Italia
Silke B. Wolfenstetter
Irene Brüske
Joachim Heinrich
Dietrich Berdel
Andrea von Berg
Irina Lehmann
Marie Standl
Christina M. Teuner
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2017
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-017-4923-2

Other articles of this Issue 1/2017

BMC Public Health 1/2017 Go to the issue